Welcome to our dedicated page for ACY news (Ticker: ACY), a resource for investors and traders seeking the latest updates and insights on ACY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ACY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ACY's position in the market.
AeroCentury Corp. reported a net loss of $13.5 million for Q2 2020, significantly down from a loss of $0.1 million in Q2 2019. Year-to-date losses reached $23.7 million, impacted by $9.7 million in impairment losses on aircraft due to reduced valuations amid the COVID-19 pandemic. The company also incurred $2 million in charges related to a credit facility conversion. Average portfolio utilization fell to 91% compared to 99% in the same quarter last year. Revenues were down 37% year-over-year, with total operating expenses up 72%.
AeroCentury reported a Q1 2020 net loss of $10.2 million ($6.58 per share), a significant decline from a $1.3 million loss in Q1 2019. Impairment losses of $6.7 million were incurred due to revised estimates for aircraft sales. The COVID-19 pandemic severely impacted customer revenues, leading to requests for lease concessions. Total revenues dropped 37% to $4.8 million year-over-year. Operating expenses surged 28% to $17.7 million, driven by increased impairments and interest expenses. As of March 31, 2020, book value per share plummeted to $8.84 from $25.59 a year ago.